ACT-02 Changes in Recurrence Pattern and Prognosis of Glioblastoma after Approval of Bevacizumab as First-line Application

Introduction: There exist controversies on recurrence and aggressiveness after use of first-line bevacizumab (BEV) which has been approved in Japan and proven to be beneficial. Therefore, we analyzed the clinical impact of BEV approval by investigating the overall clinical course and glioblastoma (G...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neurooncol Adv
Main Authors: Funakoshi, Yusuke, Hata, Nobuhiro, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Takigawa, Kosuke, Mizoguchi, Masahiro
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Supplement Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699102/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.032
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker